(Incorporated in the Cayman Islands)

We are a newly organized blank check company – the third SPAC under the Helix name. We intend to focus on the healthcare sector and healthcare-related industries in our search for a suitable target company. Our search will focus on the biotech, MedTech and life science sectors.

Bihua Chen is our CEO and chairman of the board of directors. He is the founder and managing member of Cormorant Asset Management, a healthcare investment firm.

Caleb Tripp is our CFO and COO. He is the CFO of Cormorant. 

(Note: Helix Acquisition Corp. III upsized its stock-only SPAC IPO at pricing – to 15 million shares – up from 12.5 million shares – and priced the deal at $10.00 per share – to raise $150 million on Thursday night, Jan. 22, 2026. Background: Helix Acquisition Corp. III disclosed its plans for its SPAC IPO on Dec. 8, 2025, in an S-1 filing: 12.5 million shares at $10.00 each to raise $125 million. Note: Helix Acquisition III is unusual  in that it is a stock-only offering. Most SPAC IPOs are structured as unit offerings with each unit consisting of a share of stock and a warrant (or a fraction of a warrant) – or of a right to acquire a fraction of a share of stock – upon the consummation of an initial business combination.)